Перший клінічний досвід виконання алкогольної абляції вени Маршалла в комплексному лікуванні персистентної фібриляції передсердь

В.В. Бойко, С.В. Рибчинський, Д.О. Лопін, А.С. Внукова, Д.Є. Волков

Література

1. Bai R., Di Biase L., Mohanty P. et al. Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation // Heart Rhythm.– 2016.– Vol. 13 (1).– P. 132–140. doi: 10.1016/j.hrthm.2015.08.019.
2. Boersma L., Koźluk E., Maglia G. et al. Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry // EP Europace.– 2020.– Vol. 22 (6).– P. 888–896. doi: 10.1093/europace/euaa042.
3. Brugada J., Katritsis D., Arbelo E. et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) // Eur. Heart J.– 2019.– Vol. 41 (5).– P. 655–720.  doi: 10.1093/eurheartj/ehz467.
4. Choi J., Park E., Kim H. et al. Ethanol Infusion in the Vein of Marshall in a Patient with Persistent Atrial Fibrillation // Korean Circulation J.– 2015.– Vol. 45 (5).– P. 424. doi: 10.4070/kcj.2015.45.5.424.
5. Hacking C. Vein of Marshall Radiology Reference Article Radiopaedia.org // Retrieved 25 August 2020. https://radiopaedia.org/articles/vein-of-marshall-1?lang=us.
6. Hindricks G., Potpara T., Dagres N. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) // Eur. Heart J.– 2020. doi: 10.1093/eurheartj/ehaa612.
7. Hsu L., Jaïs P., Keane D. et al. Atrial fibrillation originating from persistent left superior vena cava // Circulation, 2004.– Vol. 109 (7).– P. 828–832. doi: 10.1161/01.cir.0000116753.56467.bc.
8. Kamanu S., Tan A., Peter C. et al. Vein of Marshall activity during sustained atrial fibrillation // J. Cardiovasc. Electrophysiology.– 2006.– Vol. 17 (8).– P. 839–846. doi: 10.1111/j.1540-8167.2006.00516.x.
9. Kirchhof P., Benussi S., Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS // Eur. Heart J.– 2016.– Vol. 37 (38).– P. 2893–2962. doi: 10.1093/eurheartj/ehw210.
10. Kirchhof P., Camm A., Goette A. et al. Early rhythm-control therapy in patients with atrial fibrillation // New Engl. J. Medicine.– 2020.– Vol. 383 (14).– P. 1305–1316. doi: 10.1056/nejmoa2019422.
11. Kuck K., Brugada J., Schlüter M. et al. The FIRE AND ICE Trial: What we know, what we can still learn, and what we need to address in the future // J. Amer. Heart Association.– 2018.– Vol. 7 (24). doi: 10.1161/jaha.118.010777.
12. Lin W., Tai C., Hsieh M. et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non–pulmonary vein ectopy // Circulation.– 2003.– Vol. 107 (25).– P. 3176–3183. doi: 10.1161/01.cir.0000074206.52056.2d.
13. Margulescu A., Mont L. Persistent atrial fibrillation vs paroxysmal atrial fibrillation: differences in management // Expert Review Of Cardiovascular Therapy.– 2017.– Vol. 15 (8).– P. 601–618. doi: 10.1080/14779072.2017.1355237.
14. Nielsen J., Johannessen A., Raatikainen P. et al. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial // Retrieved.– 2020.– Vol. 27.
15. Noseworthy P., Gersh B., Kent D. et al. Atrial fibrillation ablation in practice: assessing CABANA generalizability // Eur. Heart J.– 2019.– Vol. 40 (16).– P. 1257–1264. doi: 10.1093/eurheartj/ehz085.
16. Philibert S., Amet D., De Chirac M., Laurent G. A case report of ethanol infusion in the vein of Marshall using the right jugular vein approach // Eur. Heart J. – Case Reports.– 2020. doi: 10.1093/ehjcr/ytaa260.
17. Valderrábano M. Vein of Marshall ethanol infusion for persistent atrial fibrillation – American College of Cardiology // Retrieved.– 2020.– 25 August. https://www.acc.org/latest-in-cardiology/clinical-trials/2020/03/26/22/46/venus.
18. Valderrábano M., Chen H., Sidhu J. et al. Retrograde ethanol infusion in the vein of Marshall // Circulation: Arrhythmia And Electrophysiology.– 2009.– Vol. 2 (1).– P. 50–56. doi: 10.1161/circep.108.818427.
19. Valderrábano M., Liu X., Sasaridis C. et al. Ethanol infusion in the vein of Marshall: Adjunctive effects during ablation of atrial fibrillation // Heart Rhythm.– 2009.– Vol. 6 (11).– P. 1552–1558. doi: 10.1016/j.hrthm.2009.07.036.
20. Valderrábano M., Peterson L., Bunge R. et al. Vein of Marshall ethanol infusion for persistent atrial fibrillation: VENUS and MARS clinical trial design // Amer. Heart J.– 2019.– Vol. 215.– P. 52–61. doi: 10.1016/j.ahj.2019.04.022.
21. Verma A., Sanders P., Macle L. et al. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial – Part II (STAR AF II): design and rationale // Amer. Heart J.– 2012.– Vol. 164 (1).– P. 1–6.e6. doi: 10.1016/j.ahj.2012.04.002.